Overview

Assessment of Drug Liking In Peri-procedural Clinical Settings

Status:
NOT_YET_RECRUITING
Trial end date:
2027-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether medications used in peri-procedural clinical settings can modulate drug liking.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Stanford University
Treatments:
Droperidol